Elon Musk’s Neuralink says has FDA approval for study of brain implants in humans By Akriti Sharma and Rachael Levy (Reuters) – Elon Musk’s brain-implant company Neuralink on Thursday said the U.S. Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain […]
This post first appeared on Global Banking And Finance Review Magazine – Fin, please read the originial post: here
